ALGS vs RHI · rev $2.8M vs P/E 21, rev $2.64B
Aligos Therapeutics Inc (ALGS) versus Robert Half International Inc (RHI) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Robert Half International Inc (RHI) is a staffing & employment services company listed on US.
Latest reported ALGS revenue for 2026-06-30 was $2.8M. Net income was -$24.5M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. ALGS currently screens at market cap $44.1M.
Latest reported RHI revenue for 2026-06-30 was $2.64B. Net income was $40.1M. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
ALGS currently screens at market cap $44.1M. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
Not investment advice. Open the ALGS and RHI stock pages for the full models.
Not investment advice.